Where does Lenz Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lenz Therapeutics, Inc. ranks #41,396 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lenz Therapeutics, Inc. hold?

Lenz Therapeutics, Inc. holds 6 US utility patents granted between 2021 and 2023, spanning 5 technology areas.

What is Lenz Therapeutics, Inc.'s Innovation Score?

Lenz Therapeutics, Inc. has an Innovation Score of 36.5 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Lenz Therapeutics, Inc. focus on?

Lenz Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 6 patents, ranking #3,449 of 7,163 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Lenz Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Lenz Therapeutics, Inc..

What does claim depth mean for Lenz Therapeutics, Inc.'s patents?

Lenz Therapeutics, Inc.'s patents average 14.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lenz Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Lenz Therapeutics, Inc.

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lenz ranks #41,396 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#41,396
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.5/100): 14.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R41396 · US Corporation #41,396 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #41,396/49,997
PHOTO-FINISH Leibniz-Institut…
CPC-NARROW A61K · 5 areas
INNOV-THIN 36.5/100
CLAIMS-RICH 14.2 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2023 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lenz’s 36.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (18%) Velocity 13.3 pts (37%) Breadth 7.9 pts (22%) Claim depth 8.5 pts (23%)

Qualcomm Incorporated · highest

85
Lenz Therapeutics · this assignee

36
3D Lighting… · lowest

7

What this shows Lenz's Innovation Score is 36.5/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lenz?

Each dot is one of Lenz’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lenz’s own 14.2 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Lenz vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lenz's grants concentrate

Lenz Therapeutics, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2023. By volume, Lenz sits between Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut and Lewis Bolt & Nut Company.

Lenz's three-year grant acceleration

Lenz Therapeutics, Inc. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Leibniz-institut…

6
Leishen Intellige…

6
Leman Micro Devic…

6
Lenovoemc

6
Lenze SE

6
Leo Schachter Dia…

6
Levicept

6
Lewis Bolt & Nut

6
Lenz Therapeutics ◀

6

What this shows Lenz holds 6 patents at rank #41,432, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lenz

By rank, the assignees closest to #41,432 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Lenz's primary technology class.

Lenz's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Lenz Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	33.3%
2022	3	50.0%
2023	1	16.7%

Which technologies does Lenz Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C07D - Heterocyclic Compounds 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lenz Therapeutics, Inc.'s patent record in context - here's where to go next.

Lenz Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #41,396 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lenz Therapeutics, Inc. against Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.